Stock listing
ILU Stock Price, News, Filings & Events — Illumina, Inc.
Selected listing: ILU · TRADEGATE · EUR · DE
This page tracks Illumina, Inc.'s ILU:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ILU:TRADEGATE. ILU:TRADEGATE is the stock-level entry point for investors researching Illumina, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Illumina, Inc. is a leading company in the field of genomics, specializing in DNA sequencing and array-based solutions. Based in the United States, Illumina has a market capitalization of approximately $29.37 billion. The company focuses on advancing the understanding of genetics and improving healthcare through innovative technologies.
- Ticker
- ILU:TRADEGATE
- Asset type
- Stock
- Market cap
- $33.13B
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- TRADEGATE
- Currency
- EUR
Illumina, Inc. ILU:TRADEGATE stock context
This page tracks Illumina, Inc.'s ILU:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ILU:TRADEGATE. ILU:TRADEGATE is the stock-level entry point for investors researching Illumina, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Illumina, Inc. is a leading company in the field of genomics, specializing in DNA sequencing and array-based solutions. Based in the United States, Illumina has a market capitalization of approximately $29.37 billion. The company focuses on advancing the understanding of genetics and improving healthcare through innovative technologies.
Latest news from Illumina, Inc.
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026
July 30, 2026
Illumina expands Billion Cell Atlas program with new AI drug developers
July 16, 2026
Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
July 9, 2026
Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer
July 9, 2026
Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors
June 23, 2026
Research Illumina, Inc.
Illumina, Inc. investor report
Review AI stock analysis and investor report context for ILU:TRADEGATE.
Illumina, Inc. company profile
View the public company page for Illumina, Inc. on 6ix.
Illumina, Inc. news
Read company news and market updates connected to Illumina, Inc..
Illumina, Inc. investor events
Find investor webinars, events, and replay context for Illumina, Inc..
Alternate listings
ILMN:NASDAQ
US · USD
Alternate listing for Illumina, Inc.; the primary context on this page is ILU:TRADEGATE.
ILU:GETTEX
DE · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is ILU:TRADEGATE.
1ILMN:MIL
IT · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is ILU:TRADEGATE.
927079:LSX
DE · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is ILU:TRADEGATE.
ILMN:BMV
MX · MXN
Alternate listing for Illumina, Inc.; the primary context on this page is ILU:TRADEGATE.
ILU:FWB
DE · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is ILU:TRADEGATE.
927079:LS
DE · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is ILU:TRADEGATE.
I1LM34:BMFBOVESPA
BR · BRL
Alternate listing for Illumina, Inc.; the primary context on this page is ILU:TRADEGATE.
0J8Z:LSE
GB · USD
Alternate listing for Illumina, Inc.; the primary context on this page is ILU:TRADEGATE.
ILU:SWB
DE · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is ILU:TRADEGATE.
4ILMN:EUROTLX
IT · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is ILU:TRADEGATE.
ILU:HAN
DE · EUR
Alternate listing for Illumina, Inc.; the primary context on this page is ILU:TRADEGATE.